Company Covalon Technologies Ltd Toronto S.E.

Equities

COV

CA22282D3022

Biotechnology & Medical Research

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per Business

Sales per region

Sector Other Biotechnology & Medical Research

Inactive Instrument

Covalon Technologies Ltd. is a patient-driven medical device company. Through a portfolio of patented technologies and solutions for advanced wound care, infection prevention, and medical device coatings, the Company offers gentler and more compassionate options for patients to heal with less infections, less pain, and better outcomes. Its solutions are designed for patients and made for care providers. It leverages its patented medical technology platforms and expertise in two ways: by developing products that are sold under Covalonâs name and by developing and commercializing medical products for other medical companies under development and license contracts. It provides a range of specialized medical devices, medical dressings and advanced medical technology designed for infection prevention, complex wound closure and perioperative care. Its perioperative care solutions provide antimicrobial protection of pre-operative skin, through postoperative incision care to scar prophylaxis.

CAD in Million	2022	Weight	2023	Weight	Delta
Product 89.9 %	16	90.5 %	24	89.9 %	+45.60%
Development and Consulting Services 9.2 %	1	8.2 %	2	9.2 %	+65.13%
Licensing and Royalty Fees 0.8 %	0	1.3 %	0	0.8 %	-4.11%

CAD in Million	2022	Weight	2023	Weight	Delta
United States 70.9 %	12	66.7 %	19	70.9 %	+55.76%
Middle East 22.1 %	4	22.2 %	6	22.1 %	+45.67%
Rest of the World 6.9 %	2	10.8 %	2	6.9 %	-6.76%
Canada 0.2 %	0	0.3 %	0	0.2 %	-8.17%

Managers	Title	Age	Since
Valerio DiTizio FOU	Founder	-	28/04/28
Amir Boloor CHM	Chairman	-	27/20/27
Kim Crooks COO	Chief Operating Officer	-	01/08/01
Brian Pedlar BRD	Director/Board Member	-	14/10/14
Mark Doolittle SAM	Sales & Marketing	-	19/22/19
Elaine Zhang PRN	Corporate Officer/Principal	-	01/08/01
Ron Hebert SAM	Sales & Marketing	-	26/22/26
Hector Padilla PRN	Corporate Officer/Principal	-	01/15/01
Greg Leszczynski HRO	Human Resources Officer	-	01/18/01

Members of the board	Title	Age	Since
Ronald Smith BRD	Director/Board Member	73	18/19/18
Abe Schwartz BRD	Director/Board Member	-	07/08/07
Martin Goldfarb BRD	Director/Board Member	-	23/20/23
Brian Pedlar BRD	Director/Board Member	-	14/10/14
Joseph Cordiano BRD	Director/Board Member	-	07/08/07
Samantha Nutt BRD	Director/Board Member	-	10/22/10
Amir Boloor CHM	Chairman	-	27/20/27

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	24,669,577	11,726,054 ( 47.53 %)	0	47.53 %

Name	Equities	%	Valuation
Abe Schwartz 33.08 %	8,160,912	33.08 %	7 M $
Goldfarb Corp. 16.67 %	4,111,563	16.67 %	3 M $
Brian Pedlar 3.583 %	883,876	3.583 %	709 752 $
Amir Boloor 3.525 %	869,598	3.525 %	698 287 $
Joseph Cordiano 0.6170 %	152,200	0.6170 %	122 217 $
Kim Crooks 0.1210 %	29,850	0.1210 %	23 970 $
William Blair Capital Management LLC 0.0882 %	21,770	0.0882 %	17 481 $
Ronald Smith 0.0709 %	17,500	0.0709 %	14 053 $
Samantha Nutt 0.000000 %	0	0.000000 %	- $
Katie Martinovich 0.000000 %	0	0.000000 %	- $

Covalon Technologies Ltd.

1660 Tech Avenue Unit 5

L4W 5S7, Mississauga

http://www.covalon.com

Healthcare

Pharmaceuticals & Medical Research

Biotechnology & Medical Research

Biotechnology & Medical Research

Other Biotechnology & Medical Research

	1st Jan change	Capi.
MODERNA, INC.	+43.36%	54.63B
IQVIA HOLDINGS INC.	-5.31%	39.92B
LONZA GROUP AG	+37.52%	38.82B
ICON PUBLIC LIMITED COMPANY	+14.75%	26.86B
CELLTRION, INC.	-12.56%	26.22B
ALNYLAM PHARMACEUTICALS, INC.	-22.45%	18.78B
UNITED THERAPEUTICS CORPORATION	+25.12%	12.21B
BIO-TECHNE CORPORATION	+0.04%	12.16B
MEDPACE HOLDINGS, INC.	+26.04%	11.94B

Other Biotechnology & Medical Research